Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risk of infertility related to adjuvant chemotherapy in young breast cancer patients: oocyte/embryo cryopreservation
2016-000808-28Phase 2Active
- Sponsor
- Centre Oscar Lambret
- Start
- Oct 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of follitropin alfa and follitropin beta in breast cancer, sponsored by Centre Oscar Lambret. Primary endpoint: Fertility preservation outcomes. Started Oct 2018; status: active.
02
Drugs
follitropin alfafollitropin beta
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2016-000808-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-000808-28.